Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2024 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: tracel11 who wrote (32)	1/21/2024 5:59:07 PM
From: technetium	2 Recommendations Recommended By Arthur Radley Lance Bredvold Respond to of 195

You might want to ask on Ihub’s Biotech Values board because it is more active than this one. investorshub.advfn.com You don’t have to be quite so explicit with your strategy if you don’t want to, given that a wide range of people follow the board anonymously. I personally own far fewer biotech than I have in the past because the biotech market has been rather bleak for the last few years. In addition, starting with the onset of the Covid, I’ve gone more heavily into cash, keeping at least six months worth of expenses in cash. However, since the Fed started cranking up interest rates, I’ve kept a lot of the cash in CDs and short term Treasuries, because my bank continues to pay a whopping 0.1% interest on money in my savings account. I bought more dividend focused stocks in my Roth IRA, but it’s a small part of my portfolio. I’m waiting for my ship to come in with RVNC, but since I hold it in my ROTH IRA, I can’t sell it for a tax loss. I picked IOVA in my portfolio because I think they are on the right track, but I’ve been proved wrong in the past.